AstraZeneca receives FDA approval for Koselugo to treat adults with NF1 and inoperable plexiform neurofibromas, backed by ...

Jonathan Rosenberg reflected on the CALGB 90601 trial—a negative study in advanced bladder cancer that, despite its challenges and lack of survival benefit, yielded valuable biospecimens and spurred ...